These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32903249)

  • 1. COVID-19 and Hypercoagulability.
    Sholzberg M
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
    Shi W; Lv J; Lin L
    J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 coagulopathy: An in-depth analysis of the coagulation system.
    Martín-Rojas RM; Pérez-Rus G; Delgado-Pinos VE; Domingo-González A; Regalado-Artamendi I; Alba-Urdiales N; Demelo-Rodríguez P; Monsalvo S; Rodríguez-Macías G; Ballesteros M; Osorio-Prendes S; Díez-Martín JL; Pascual Izquierdo C
    Eur J Haematol; 2020 Dec; 105(6):741-750. PubMed ID: 32749010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolic events and Covid-19.
    Ribes A; Vardon-Bounes F; Mémier V; Poette M; Au-Duong J; Garcia C; Minville V; Sié P; Bura-Rivière A; Voisin S; Payrastre B
    Adv Biol Regul; 2020 Aug; 77():100735. PubMed ID: 32773098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
    Beun R; Kusadasi N; Sikma M; Westerink J; Huisman A
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):19-20. PubMed ID: 32311843
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from the Italian COVID-19 frontline.
    Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
    Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.
    Magro G
    Med Hypotheses; 2020 Sep; 142():109829. PubMed ID: 32428809
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
    Marzolini C; Stader F; Stoeckle M; Franzeck F; Egli A; Bassetti S; Hollinger A; Osthoff M; Weisser M; Gebhard CE; Baettig V; Geenen J; Khanna N; Tschudin-Sutter S; Mueller D; Hirsch HH; Battegay M; Sendi P
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32641296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
    Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
    Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan.
    Tu WJ; Cao J; Yu L; Hu X; Liu Q
    Intensive Care Med; 2020 Jun; 46(6):1117-1120. PubMed ID: 32253448
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 and SIC (!).
    Nevzorov I; Tulamo R; Albäck A; Lassila R
    J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
    [No Abstract]   [Full Text] [Related]  

  • 12. Foreword for the special issue advances in COVID-19: Biology and clinic.
    McCubrey JA; Akula SM; Payrastre B
    Adv Biol Regul; 2020 Aug; 77():100744. PubMed ID: 32773104
    [No Abstract]   [Full Text] [Related]  

  • 13. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
    Tal S; Spectre G; Kornowski R; Perl L
    Acta Haematol; 2020; 143(5):417-424. PubMed ID: 32396903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
    Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D
    Emerg Infect Dis; 2020 Aug; 26(8):1941-1943. PubMed ID: 32348233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
    Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
    Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plea for the pathogenic role of immune complexes in severe Covid-19.
    Vuitton DA; Vuitton L; Seillès E; Galanaud P
    Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening.
    Tavazzi G; Civardi L; Caneva L; Mongodi S; Mojoli F
    Intensive Care Med; 2020 Jun; 46(6):1121-1123. PubMed ID: 32322918
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.
    Lee WS; Margolskee E
    Blood; 2020 Aug; 136(7):914. PubMed ID: 32790856
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 20. A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients.
    Roncati L; Ligabue G; Nasillo V; Lusenti B; Gennari W; Fabbiani L; Malagoli C; Gallo G; Giovanella S; Lupi M; Salviato T; Paolini A; Costantini M; Trenti T; Maiorana A
    Platelets; 2020 Nov; 31(8):1085-1089. PubMed ID: 32857624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.